SPAG9 and nonpapillary renal cell carcinoma: A previous study found that SPAG9 overexpression promotes proliferation and migration in the ccRCC cell lines Caki-1 and NII-AKS413 [4]; however, studies on the prognostic value of SPAG9 in ccRCC patients are still lacking.